Johnson & Johnson Pauses Trial Of Experimental COVID Vaccine After Volunteer Develops ‘Unexplained Illness’

CBS 2

13 Oct 2020 0 shares 1 views

Johnson & Johnson Pauses Trial Of Experimental COVID Vaccine After Volunteer Develops ‘Unexplained Illness’

Johnson & Johnson Pauses Trial Of Experimental COVID Vaccine After Volunteer Develops ‘Unexplained Illness’

CBS 2

Published 13 Oct 2020

Johnson & Johnson says the patient's condition is now being evaluated by an independent data monitoring board, along with its own physicians.

You might like

Related news coverage

FDA OKs Pfizer To Test COVID-19 Vaccine On Kids As Young As 12

FDA OKs Pfizer To Test COVID-19 Vaccine On Kids As Young As 12

Newsy 15 Oct 2020

Watch VideoFor Elizabeth Power of Nebraska, like so many parents in this pandemic, the well-being of her three children is most..

AstraZeneca resuming US testing of COVID-19 vaccine
SeattlePI.com 23 Oct 2020
Johnson Johnson pauses coronavirus vaccine trial after participant contracts "unexplained illness"
NaturalNews.com 21 Oct 2020
Johnson Johnson's aborted baby Covid-19 vaccine harms trial participant
NaturalNews.com 15 Oct 2020
Asian shares track Wall Street decline on pandemic jitters
SeattlePI.com 14 Oct 2020

Advertisement

More coverage

Johnson & Johnson Covid-19 Vaccine On Hold

Johnson & Johnson Covid-19 Vaccine On Hold

Newsy 13 Oct 2020

Watch VideoThe race for an approved COVID-19 vaccine is dealing with a setback. Johnson & Johnson has paused their late stage..

S&P/ASX 200 dips below flatline as miners and banks weigh the market down
Proactive Investors 14 Oct 2020
Johnson & Johnson pauses its coronavirus vaccine trial because of a volunteer’s ‘unexplained illness.’
NYTimes.com 13 Oct 2020
US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern
The Age 13 Oct 2020
US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure'
Sydney Morning Herald 13 Oct 2020